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A corrigendum on
Chronic Pyruvate Supplementation Increases Exploratory Activity and Brain Energy Reserves
in Young and Middle-Aged Mice
by Koivisto, H., Leinonen, H., Puurula, M., Hafez, H. S., Alquicer Barrera, G., Stridh, M. H., et al.
(2016). Front. Aging Neurosci. 8:41. doi: 10.3389/fnagi.2016.00041
In the Original Research article there was an error in the Section “Treatment” under the section
“Methods” about the estimated daily intake of pyruvate:
“With the average food intake of 4 g this corresponds to 800mg of pyruvate/day, which is at the
upper range of effective pyruvate doses in earlier in vivo studies (Suh et al., 2005; Fukushima et al.,
2009; Isopi et al., 2014).”
As correctly stated in the Abstract, the estimated dose was 800mg of pyruvate/kg/day.
The corrected version of this section is shown below:
Treatment
Chronic Pyruvate Administration
The test group (PYR) received experimental chow supplemented with 0.6 % (w) of Na-pyruvate
(Safe Diets, Augy, France). The control group (STD) received the same basic rodent chow (A04, Safe
Diets). With the average food intake of 4 g this corresponds to 800mg of pyruvate/kg/day, which is
at the upper range of effective pyruvate doses in earlier in vivo studies (Suh et al., 2005; Fukushima
et al., 2009; Isopi et al., 2014). Acute pyruvate administration. The mice received Na-pyruvate
(Sigma, St. Louis, MO, USA) 500 mg/kg i.p. or the same molar concentration of NaCl (260 mg/kg
i.p.). This single dose affords neuroprotection against cortical concussion injury and increases
brain glucose and pyruvate levels as measured by in vivo microdialysis (Fukushima et al., 2009).
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All cage labels about the treatment groups were coded so that the
researchers running behavioral tests or assays on post-mortem
samples were blinded as to the treatment.
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